Erasmus University Medical Centre
Rotterdam, NLD
BIOSKETCH – CHRIS H. BANGMA
Chris H. Bangma (born 4th January 1959) was nominated Professor and Chairman of the Department of Urology at Erasmus University Medical Centre in Rotterdam, The Netherlands, in 2002.
Chris spent a two year fellowship at Baylor College of Medicine, Houston, USA, with Prof Timothy Thompson and Peter Scardino, and afterwards at the oncology lab of Prof. Bob Pinedo at the Free University in Amsterdam.
Chris Bangma participated in the European Fifth Framework Program from 2000 onwards on the preclinical development of gene therapeutic vectors, followed by coordinating the clinical application in the GIANT consortium within the European Sixth Framework Program. A clinical Phase 1-2 trial is currently running on neoadjuvant virolytic therapy for Pca.
He is board member of the European Randomised study on Screening of Prostate Cancer ERSPC from 1992, and has coordinated the European P-Mark consortium since 2004 till 2008 for the search and validation of prognostic serum markers for prostate cancer.
Furthermore, he is PI of the PRIAS project on Active Surveillance since 2006, and the Global Action Plan 3 on Active Surveillance for Movember since 2014, the PRO-NEST Marie Curie Training program, PCMM (Dutch integrated academia – industry program), and the STW-Dutch Cancer Society program (2016) on automatization and visualisation of prognostic parameters in decision making in prostate cancer.
Chris Bangma is the founder of the first multidisciplinary prostate centre in the Netherlands in 2010, and the network raised following named ProstatePartners (2014).
Chris has contributed to over 200 peer reviewed papers predominantly in the field of prostate and bladder carcinoma. As past President of the Dutch Urologic Society, he is Chairman of the Dutch Convent of Academic Professors in Urology. Amongst memberships of societies and committees, he is a member of AAGUS (2006) and of the Scientific Committee of the EAU.
Disclosure information not submitted.